To address this, we explored mRNA of lung cancer patients from The Cancer Genome Atlas (TCGA) where we found that RASSF1A expression positively correlates with a good prognosis and overall survival in lung adenocarcinoma patients but not in squamous cell carcinomas (Fig 1A). Here, RASSF1 is linked to lung carcinoma.